Literature DB >> 18464320

Effective treatment of steroid refractory adult-onset Still's disease with anakinra.

Judith Maier, Gabriele Birkenfeld, Jochen Pfirstinger, Jürgen Schölmerich, Martin Fleck, Hilke Brühl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18464320

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  8 in total

1.  Therapeutic responses and prognosis in adult-onset Still's disease.

Authors:  Hyoun-Ah Kim; Jun-Mo Sung; Chang-Hee Suh
Journal:  Rheumatol Int       Date:  2011-01-29       Impact factor: 2.631

Review 2.  Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

Authors:  R Goldbach-Mansky
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 3.  Autoinflammation: translating mechanism to therapy.

Authors:  Taylor A Doherty; Susannah D Brydges; Hal M Hoffman
Journal:  J Leukoc Biol       Date:  2011-02-17       Impact factor: 4.962

4.  [IL-1 antagonists].

Authors:  I Kötter; G Horneff
Journal:  Z Rheumatol       Date:  2010-09       Impact factor: 1.372

Review 5.  Therapy of autoinflammatory syndromes.

Authors:  Hal M Hoffman
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

6.  Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: a case-series study.

Authors:  Katerina Laskari; Athanasios G Tzioufas; Haralampos M Moutsopoulos
Journal:  Arthritis Res Ther       Date:  2011-06-17       Impact factor: 5.156

7.  Anti-Interleukin-1 Agents in Adult Onset Still's Disease.

Authors:  Cecilia Giampietro; Bruno Fautrel
Journal:  Int J Inflam       Date:  2012-04-29

8.  Adult-Onset Still's Disease Masquerading as Sepsis in an Asplenic Active Duty Soldier.

Authors:  Nathan T Jaqua; David Finger; Joshua S Hawley
Journal:  Case Rep Med       Date:  2012-11-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.